Fibromuscular dysplasia and coronary artery fistula: links to pulmonary hypertension.
作者信息
Zheng Wen Qian, Kumar Suchet, El-Hajjar Mohammad
机构信息
Internal Medicine, Albany Medical College, Albany, New York, USA
Cardiology, Albany Medical College, Albany, New York, USA.
出版信息
BMJ Case Rep. 2020 Mar 24;13(3):e234698. doi: 10.1136/bcr-2020-234698.
Abstract
摘要
相似文献
1
Fibromuscular dysplasia and coronary artery fistula: links to pulmonary hypertension.纤维肌性发育不良与冠状动脉瘘：与肺动脉高压的关联
BMJ Case Rep. 2020 Mar 24;13(3):e234698. doi: 10.1136/bcr-2020-234698.
2
Living With Severe Pulmonary Arterial Hypertension Without an Infusion Pump? Selexipag has a Role to Play.在没有输液泵的情况下应对重度肺动脉高压？司来帕格可发挥作用。
Arch Bronconeumol (Engl Ed). 2019 Feb;55(2):102-103. doi: 10.1016/j.arbres.2018.03.010. Epub 2018 Jul 27.
3
Ambrisentan (Letairis) and tadalafil (Adcirca) for pulmonary arterial hypertension.
Med Lett Drugs Ther. 2016 Jan 4;58(1485):2-4.
4
The status of pulmonary arterial hypertension in 2008.2008年肺动脉高压的状况
Circulation. 2008 Jun 10;117(23):2966-8. doi: 10.1161/CIRCULATIONAHA.108.782979.
5
Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.双重磷酸二酯酶5抑制剂疗法治疗难治性肺动脉高压：一项试点研究。
BMC Pulm Med. 2015 May 14;15:62. doi: 10.1186/s12890-015-0037-8.
6
First data from Latvian chronic thromboembolic pulmonary hypertension registry.来自拉脱维亚慢性血栓栓塞性肺动脉高压登记处的首批数据。
Eur J Intern Med. 2016 Jul;32:e23-4. doi: 10.1016/j.ejim.2016.01.017. Epub 2016 Feb 4.
7
Screening and Early Detection of Pulmonary Arterial Hypertension in Connective Tissue Diseases. It Is Time to Institute It!结缔组织病中肺动脉高压的筛查与早期检测。是时候开展这项工作了！
Am J Respir Crit Care Med. 2015 Nov 1;192(9):1032-3. doi: 10.1164/rccm.201509-1881ED.
8
Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment.肺动脉高压患者联合治疗的血浆药物浓度。
Respiration. 2017;94(1):26-37. doi: 10.1159/000470916. Epub 2017 May 12.
9
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial.安立生坦与他达拉非初始联合治疗结缔组织病相关肺动脉高压（CTD-PAH）：来自AMBITION试验的亚组分析
Ann Rheum Dis. 2017 Jul;76(7):1219-1227. doi: 10.1136/annrheumdis-2016-210236. Epub 2016 Dec 30.
10
Novel Documentation of Onset and Rapid Advancement of Pulmonary Arterial Hypertension without Symptoms in BMPR2 Mutation Carriers: Cautionary Tales?BMPR2 基因突变携带者肺动脉高压无症状起病及快速进展的新记录：警示故事？
Am J Respir Crit Care Med. 2020 Dec 1;202(11):1587-1589. doi: 10.1164/rccm.202005-1611LE.
本文引用的文献
1
First International Consensus on the diagnosis and management of fibromuscular dysplasia.第一届国际纤维肌发育不良诊断与管理共识会议。
Vasc Med. 2019 Apr;24(2):164-189. doi: 10.1177/1358863X18821816. Epub 2019 Jan 16.
2
Coronary Artery Fistula.冠状动脉瘘
Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):78-80. doi: 10.14797/mdcj-13-2-78.
3
Dissection and Aneurysm in Patients With Fibromuscular Dysplasia: Findings From the U.S. Registry for FMD.纤维肌发育不良患者的夹层和动脉瘤：来自美国纤维肌发育不良登记处的研究结果。
J Am Coll Cardiol. 2016 Jul 12;68(2):176-85. doi: 10.1016/j.jacc.2016.04.044.
4
The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients.美国纤维肌发育不良注册研究：447 例患者的初步结果。
Circulation. 2012 Jun 26;125(25):3182-90. doi: 10.1161/CIRCULATIONAHA.112.091223. Epub 2012 May 21.
5
Juvenile pulmonary hypertension associated with fibromuscular dysplasia.
Intern Med. 2010;49(22):2487-92. doi: 10.2169/internalmedicine.49.3816. Epub 2010 Nov 15.
6
Coronary artery fistulas: how to manage them.冠状动脉瘘：如何进行治疗。
Catheter Cardiovasc Interv. 2007 Jul 1;70(1):110-6. doi: 10.1002/ccd.21125.
7
Thromboembolic pulmonary hypertension due to disseminated fibromuscular dysplasia.
Pediatr Cardiol. 1996 Sep-Oct;17(5):340-5. doi: 10.1007/s002469900076.
8
Arterial fibromuscular dysplasia.动脉纤维肌发育不良
Mayo Clin Proc. 1987 Oct;62(10):931-52. doi: 10.1016/s0025-6196(12)65051-4.
Zotero 插件